Literature DB >> 9180286

Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics.

R Costello1, D Sainty, P Lecine, A Cusenier, M J Mozziconacci, C Arnoulet, D Maraninchi, J A Gastaut, J Imbert, M Lafage-Pochitaloff, J Gabert.   

Abstract

Pericentric inversion of chromosome 16, translocation (16;16) and del(16q), resulting in a chimerical fusion of CBFbeta and MYH11 genes, are typically seen in the M4Eo French-American-British (FAB) classification subset of acute myelogenous leukemia (AML). In this study, we analyzed 70 cases of acute non-lymphoblastic leukemia, mainly of the M4 or M5 type. We report the very unusual presence of the t(16;16) and CBFbeta/MYH11 fusion transcript in an M7 patient. Ten M4Eo and four non-M4Eo patients presented an inv(16), t(16;16) or CBFbeta/MYH11 fusion transcript. In most cases, the common 'A-type' CBFbeta/MYH11 fusion transcript was detected. In addition to the eight different breakpoints and the three alternative splicing variants already described, evidence of a new CBFbeta/MYH11 fusion transcript was found which involves a 785-bp deletion of MYH11. Moreover, two patients had an unusual transcript, to our knowledge only observed once. Only one patient had abnormal eosinophilic differentiation without chromosome 16 cytogenetic abnormalities or detectable CBFbeta/MYH11 fusion. Conversely, only one patient presented CBFbeta/MYH11 fusion without abnormal eosinophilic differentiation. Altogether, our data suggest a correlation between the CBFbeta/MYH11 fusion transcript and characteristic abnormal eosinophilic differentiation, whatever the FAB subtype or the percentage of abnormal eosinophils

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180286     DOI: 10.1038/sj.leu.2400629

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  2 in total

1.  Exon-skipping in BCR/ABL is induced by ABL exon 2.

Authors:  B D Lichty; S Kamel-Reid
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

2.  miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.

Authors:  John Fischer; Stefano Rossetti; Arani Datta; Kevin Eng; Alessandro Beghini; Nicoletta Sacchi
Journal:  Mol Cancer       Date:  2015-01-23       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.